RTN2 : A Randomised Trial of Post-operative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck (Other IDs: TROG 08.09, 2009/039, ANZMTG 01.09)

Male or<br/>FemaleGender Male or
Female

RecruitingStatus Recruiting

Multiple<Br/>Treatment TypesTypeMultiple
Treatment Types

ThreePhase Three

18-75Age 18-75

Advanced CancersCancer LocationMulti-Cancer
Trial

Multiple treatment types,Surgical,Systemic therapy | Head and neck,SkinHead and neck,Melanoma (Skin)

Trial Overview Read MoreRead more

This phase III trial is comparing surgery alone and in combination with radiation therapy for the treatment of primary melanoma that has histoglogical features of neurotropism.
 

This trial is treating patients with Melanoma.

This is a surgical and systemic therapy.

You may be able to join this trial if:

  • You have had a certain type of treatment or surgical procedure.
  • Your cancer has not spread to other parts of the body.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have been diagnosed with a prior or secondary type of cancer.
  • You have had certain treatments, surgical procedures or drugs.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

A Randomised Trial of Post-operative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck (Other IDs: TROG 08.09, 2009/039, ANZMTG 01.09)

Cooperative Group

Trans Tasman Radiation Oncology Group (TROG)

Summary

Melanoma is the third most common cancer in Australia. Approx 1000 Australians die of the disease each year. Neurotropism, defined as invasion by melanoma of peripheral neural tissue, is uncommon but it is this feature which is linked with a high risk of the cancer coming back in the same area. The primary aim of this trial is to determine if there is a difference in the rate of relapse between 2 randomised groups of patients treated after surgery with either radiation therapy or initial observation

Recruiting Hospitals Read MoreRead more

Alfred Hospital, William Buckland Radiotherapy Centre
Prahran
Ms Robin Smith
robin.smith@wbrc.org.au
03 9076 2360

Not Recruiting Hospitals Read MoreRead more

Closed

Peter MacCallum Cancer Centre, Surgery
Parkville
Ms Tina Thorpe
tina.thorpe@petermac.org
03 9656 1521

Completed

Peter MacCallum Cancer Centre
Moorabbin
Moorabbin Research
moorabbin.research@petermac.org
03 9928 8994

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.

Next